The contribution of voxel-based morphometry in staging patients with mild cognitive impairment

M. Bozzali, M. Filippi, G. Magnani, M. Cercignani, M. Franceschi, E. Schiatti, S. Castiglioni, R. Mossini, M. Falautano, G. Scotti, G. Comi, A. Falini

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: To assess whether different patterns of regional gray matter loss in patients with mild cognitive impairment (MCI) are associated with different risks of conversion to Alzheimer disease (AD), using MRI and voxel-based morphometry (VBM). METHODS: The authors recruited 22 patients with MCI, 22 patients with probable AD, and 20 healthy subjects (HS). T1 volumes from each subject were postprocessed according to an optimized VBM protocol. All patients were clinically followed up (mean [SD] time = 28.7 [5.7] months), and patients with MCI were reclassified into two groups (converters and nonconverters to AD). RESULTS: When comparing patients with AD to HS, widespread areas of reduced gray matter density were found predominantly in temporal, frontal, and parietal lobes and in the insula. Comparing MCI converters and nonconverters with HS, the converters showed more widespread areas of reduced gray matter density than nonconverters, with a pattern of abnormalities similar to that seen in patients with AD. Conversely, when comparing the same groups with patients with AD, MCI nonconverters showed a pattern of gray matter density similar to that of HS. Areas of decreased gray matter density were also found in MCI converters compared with nonconverters. CONCLUSIONS: Different patterns of gray matter density distribution in patients with mild cognitive impairment may be associated to different rates of conversion to Alzheimer disease.

Original languageEnglish
Pages (from-to)453-460
Number of pages8
JournalNeurology
Volume67
Issue number3
DOIs
Publication statusPublished - Aug 2006

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'The contribution of voxel-based morphometry in staging patients with mild cognitive impairment'. Together they form a unique fingerprint.

  • Cite this